skip to Main Content

Cancer Services

Head and Neck Cancer

Name: SGNLV-005

Open-Label Phase 2 Study of Ladiratuzumab Vedotin (LV) for unresectable locally advanced metastatic  solid tumours.

Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Head and Neck Cancer
External page link More information about SGNLV-005

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top